Normal View Dyslexic View

Mesenteric versus conventional approach during pancreatoduodenectomy for pancreatic ductal adenocarcinoma (MAPLE-PD trial): A multicenter randomized controlled trial

BJSA
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Hirono S, Kitahata Y, Motobayashi H, Satoi S, Sho M, Takami H et al.
Ann Surg 2026; 283: 581-592.
Some 360 patients were followed for median of 39.3 months, and the two groups had similar median overall survival (hazard ratio 1.02, 95 per cent confidence interval 0.76 to 1.37, P=0.897). The mean change in circulating tumour DNA copy number from immediately after laparotomy to just before removal of specimen was significantly different, with a drop in levels observed in the mesenteric group (10.2 ±2.6 versus -7.3 ±2.6 copies, P<0.0001).
Comment: No survival advantage found with the SMA-first approach, despite more favorable intraoperative ctDNA dynamics.

Related articles


Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trial.

Bang JY, Lakhtakia S, Thakkar S, Buxbaum JL, Waxman I, Sutton B et al, on behalf of the United States Pancreatic Disease Study Group.

16 August 2024

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

Labori KJ, Bratlie SO, Andersson B, Angelsen J-H, Biorserud C, Bjornsson B et al, for the Nordic Pancreatic Cancer Trial-1 study group.

30 August 2024
Copied!